Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

1.10USD
17 Dec 2018
Change (% chg)

$0.02 (+1.85%)
Prev Close
$1.08
Open
$1.10
Day's High
$1.10
Day's Low
$1.10
Volume
2,947
Avg. Vol
95,617
52-wk High
$3.30
52-wk Low
$0.47

Chart for

About

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary... (more)

Overall

Beta: --
Market Cap(Mil.): $55.04
Shares Outstanding(Mil.): 35.51
Dividend: --
Yield (%): --

Financials

  BLPH.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.39 -- --
ROI: -187.88 9.01 14.96
ROE: -359.90 10.15 16.52

Earnings vs. Estimates